Last Price
0.006
Today's Change
+0.001 (20.00%)
Day's Change
0.005 - 0.006
Trading Volume
874,634
Market Cap
31 Million
Shares Outstanding
5 Billion
Avg Volume
12,322,041
Avg Price (50 Days)
0.00
Avg Price (200 Days)
0.01
PE Ratio
-0.60
EPS
-0.01
Earnings Announcement
28-Feb-2024
Previous Close
0.01
Open
0.01
Day's Range
0.005 - 0.006
Year Range
0.003 - 0.0085
Trading Volume
874,634
1 Day Change
20.00%
5 Day Change
0.00%
1 Month Change
20.00%
3 Month Change
20.00%
6 Month Change
-14.29%
Ytd Change
-14.29%
1 Year Change
-14.29%
3 Year Change
-79.31%
5 Year Change
-85.71%
10 Year Change
-96.67%
Max Change
-98.80%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.